Search research articles
Contact Us
Filters
Showing results (61-70 of 393) with videos related to
Page
of 40
Sort By:
Chinese Clinical Oncology
|
November 11, 2016
Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations
Lorena Marcano-Bonilla, Essa A Mohamed, Taofic Mounajjed, et al.
Gastroenterology
|
November 8, 2018
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
Renumathy Dhanasekaran, Jean-Charles Nault, Lewis R Roberts, et al.
Journal of Hepatology
|
October 10, 2015
Clinical implications of basic research in hepatocellular carcinoma
Renumathy Dhanasekaran, Sudhakar K Venkatesh, Michael S Torbenson, et al.
Journal of Clinical Gastroenterology
|
April 10, 2020
Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC Diagnosis
Samuel O Antwi, Zhuo Li, Kabir Mody, et al.
Future Oncology (London, England)
|
December 18, 2008
Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets
Jin-Ping Lai, James R Thompson, Dalbir S Sandhu, et al.
Expert Review of Gastroenterology & Hepatology
|
December 17, 2008
Treatment options for hepatocellular carcinoma
Dalbir S Sandhu, Vivek S Tharayil, Jin-Ping Lai, et al.
Hepatology (Baltimore, Md.)
|
April 3, 2015
Metformin does not improve survival of cholangiocarcinoma patients with diabetes
Zhen Yang, Xiaodan Zhang, Rosebud O Roberts, et al.
Frontiers in Oncology
|
May 23, 2022
RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
Kurt Sartorius, Samuel O Antwi, Anil Chuturgoon, et al.
Journal of Gastrointestinal Cancer
|
April 18, 2009
The tumor suppressor function of human sulfatase 1 (SULF1) in carcinogenesis
Jin-Ping Lai, Dalbir S Sandhu, Abdirashid M Shire, et al.
Hepatology (Baltimore, Md.)
|
January 5, 2020
REPLY
Ju Dong Yang, Kristin C Mara, Gregory J Gores, et al.
Page
of 40
Search research articles
Search
Showing results (61-70 of 393) with videos related to
Sort By:
Page
of 40
Chinese Clinical Oncology
|
November 11, 2016
Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations
Lorena Marcano-Bonilla, Essa A Mohamed, Taofic Mounajjed, et al.
Gastroenterology
|
November 8, 2018
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
Renumathy Dhanasekaran, Jean-Charles Nault, Lewis R Roberts, et al.
Journal of Hepatology
|
October 10, 2015
Clinical implications of basic research in hepatocellular carcinoma
Renumathy Dhanasekaran, Sudhakar K Venkatesh, Michael S Torbenson, et al.
Journal of Clinical Gastroenterology
|
April 10, 2020
Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC Diagnosis
Samuel O Antwi, Zhuo Li, Kabir Mody, et al.
Future Oncology (London, England)
|
December 18, 2008
Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets
Jin-Ping Lai, James R Thompson, Dalbir S Sandhu, et al.
Expert Review of Gastroenterology & Hepatology
|
December 17, 2008
Treatment options for hepatocellular carcinoma
Dalbir S Sandhu, Vivek S Tharayil, Jin-Ping Lai, et al.
Hepatology (Baltimore, Md.)
|
April 3, 2015
Metformin does not improve survival of cholangiocarcinoma patients with diabetes
Zhen Yang, Xiaodan Zhang, Rosebud O Roberts, et al.
Frontiers in Oncology
|
May 23, 2022
RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
Kurt Sartorius, Samuel O Antwi, Anil Chuturgoon, et al.
Journal of Gastrointestinal Cancer
|
April 18, 2009
The tumor suppressor function of human sulfatase 1 (SULF1) in carcinogenesis
Jin-Ping Lai, Dalbir S Sandhu, Abdirashid M Shire, et al.
Hepatology (Baltimore, Md.)
|
January 5, 2020
REPLY
Ju Dong Yang, Kristin C Mara, Gregory J Gores, et al.
Page
of 40